0,928  0,002  UGT1A9 substrate
0,914  0,002  NOS2 expression inhibitor
0,913  0,002  Monophenol monooxygenase inhibitor
0,901  0,003  CYP2C19 substrate
0,878  0,001  Melanin inhibitor
0,862  0,002  UGT1A3 substrate
0,861  0,003  Skin whitener
0,853  0,002  UGT1A1 substrate
0,855  0,004  Chemoprotective
0,823  0,008  Caspase 9 stimulant
0,815  0,006  Antihypercholesterolemic
0,822  0,014  Apoptosis agonist
0,799  0,005  Chemopreventive
0,791  0,004  Antioxidant
0,787  0,004  Lipoxygenase inhibitor
0,780  0,005  Sensitization
0,774  0,019  Antiinflammatory
0,768  0,015  Transcription factor NF kappa B inhibitor
0,751  0,006  CYP1A2 substrate
0,747  0,005  Caspase 3 stimulant
0,746  0,011  TNF expression inhibitor
0,739  0,010  15-Lipoxygenase inhibitor
0,728  0,005  Free radical scavenger
0,717  0,004  MAO inhibitor
0,714  0,002  Estrogen receptor alpha antagonist
0,715  0,009  Respiratory analeptic
0,704  0,005  UDP-glucuronosyltransferase substrate
0,723  0,030  Alpha-glucosidase inhibitor
0,692  0,005  UGT1A6 substrate
0,690  0,005  Antimutagenic
0,682  0,007  Proliferative diseases treatment
0,694  0,021  Antineoplastic (breast cancer)
0,664  0,002  UGT2B15 substrate
0,668  0,008  Cardiovascular analeptic
0,662  0,005  CYP2C19 inhibitor
0,661  0,006  Histamine release inhibitor
0,661  0,007  AR expression inhibitor
0,657  0,002  Neurotrophic factor enhancer
0,653  0,010  Analeptic
0,641  0,006  CYP1A2 inhibitor
0,640  0,009  Antiosteoporotic
0,646  0,020  Antidiabetic
0,646  0,020  Cyclophilin D inhibitor
0,618  0,003  Aromatase inhibitor
0,615  0,003  Beta glucuronidase inhibitor
0,617  0,005  Genotoxic
0,617  0,008  Antineoplastic (brain cancer)
0,619  0,012  Bone diseases treatment
0,616  0,009  Nitric oxide antagonist
0,610  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,605  0,004  Amylase inhibitor
0,590  0,004  MAO B inhibitor
0,588  0,005  Antihypoxic
0,586  0,004  VCAM1 expression inhibitor
0,588  0,011  Apoptosis antagonist
0,586  0,014  Spasmolytic
0,578  0,009  Amyloid beta aggregation inhibitor
0,572  0,003  Estrogen receptor beta antagonist
0,570  0,010  Hypoglycemic
0,564  0,006  Antihypertriglyceridemic
0,562  0,010  Antiamyloidogenic
0,564  0,026  Antibacterial
0,552  0,020  Carcinogenic
0,534  0,004  Estrogen antagonist
0,562  0,035  Antineoplastic (lung cancer)
0,528  0,003  Antihemorrhagic
0,533  0,009  Vascular (periferal) disease treatment
0,536  0,014  Antiparasitic
0,537  0,018  12-Lipoxygenase inhibitor
0,548  0,032  Antileukemic
0,526  0,015  Antineoplastic (glioma)
0,528  0,018  Cytostatic
0,542  0,034  CYP3A4 substrate
0,540  0,036  Alzheimer's disease treatment
0,511  0,009  Myocardial infarction treatment
0,504  0,005  Protein-tyrosine phosphatase inhibitor
0,515  0,020  Cardioprotectant
0,498  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,510  0,020  Hepatic disorders treatment
0,508  0,024  CYP2D6 substrate
0,495  0,012  Vasodilator
0,492  0,010  Antihelmintic
0,478  0,004  SULT1A3 substrate
0,497  0,023  Radioprotector
0,487  0,016  Antipyretic
0,497  0,032  Prostate cancer treatment
0,491  0,027  CYP2C9 inhibitor
0,470  0,006  Lipid peroxidase inhibitor
0,475  0,013  Antineoplastic enhancer
0,494  0,033  Teratogen
0,462  0,006  5 Hydroxytryptamine uptake stimulant
0,456  0,004  Xanthine oxidase inhibitor
0,471  0,020  Antiprotozoal (Leishmania)
0,478  0,027  Cytotoxic
0,448  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,458  0,021  ICAM1 expression inhibitor
0,448  0,013  Antiulcerative
0,440  0,010  Hepatoprotectant
0,450  0,028  Lipoprotein disorders treatment
0,428  0,009  Antihypotensive
0,448  0,032  Antifungal
0,442  0,029  NOS3 expression inhibitor
0,417  0,004  Cholesterol synthesis inhibitor
0,453  0,043  Antineoplastic (colorectal cancer)
0,447  0,037  Embryotoxic
0,453  0,046  Immunosuppressant
0,433  0,026  Mutagenic
0,410  0,004  Estrogen agonist
0,427  0,023  Antineoplastic (glioblastoma multiforme)
0,407  0,004  Histidine decarboxylase inhibitor
0,451  0,048  Antipruritic, allergic
0,404  0,011  UGT2B7 substrate
0,401  0,008  NOS3 expression enhancer
0,396  0,003  Estrogen receptor beta agonist
0,435  0,043  Antineoplastic (colon cancer)
0,414  0,024  Superoxide dismutase inhibitor
0,420  0,033  CTGF expression inhibitor
0,414  0,028  UGT2B4 substrate
0,418  0,033  Antineoplastic (cervical cancer)
0,426  0,043  Antithrombotic
0,381  0,005  Breast cancer-resistant protein inhibitor
0,386  0,014  GST M1-1 substrate
0,409  0,039  Antineoplastic (melanoma)
0,384  0,017  UGT1A4 substrate
0,403  0,037  Antineoplastic (pancreatic cancer)
0,369  0,004  Electron transport complex I inhibitor
0,371  0,008  Acetylcholinesterase inhibitor
0,364  0,006  5-Lipoxygenase inhibitor
0,357  0,003  Ornithine decarboxylase inhibitor
0,410  0,059  CYP2C9 substrate
0,353  0,011  MAO A inhibitor
0,378  0,037  Antidiabetic (type 2)
0,383  0,048  Antineoplastic (ovarian cancer)
0,340  0,005  Dementia treatment
0,349  0,016  Antineoplastic (squamous cell carcinoma)
0,338  0,005  Vascular dementia treatment
0,364  0,032  Antidiabetic symptomatic
0,372  0,055  Streptokinase A inhibitor
0,338  0,023  Platelet adhesion inhibitor
0,322  0,010  Sulfotransferase substrate
0,333  0,023  P-glycoprotein inhibitor
0,316  0,009  UGT2B9 substrate
0,318  0,012  Cyclooxygenase 1 inhibitor
0,307  0,011  Alkaline phosphatase inhibitor
0,335  0,039  Hypolipemic
0,311  0,015  Protein kinase stimulant
0,288  0,004  Antiviral (Coronavirus)
0,288  0,004  Antiviral (SARS coronavirus)
0,303  0,022  Pneumotoxic
0,292  0,011  Heat shock protein 90 antagonist
0,329  0,048  Antineoplastic (non-small cell lung cancer)
0,327  0,047  Antiprotozoal (Trypanosoma)
0,283  0,003  Ca(v)3.1 blocker
0,288  0,011  Cystathionine beta-synthase inhibitor
0,304  0,028  Dual specificity phosphatase inhibitor
0,289  0,015  Phospholipase A2 inhibitor
0,291  0,020  Cholinergic
0,316  0,046  Transcription factor STAT3 inhibitor
0,280  0,010  Expectorant
0,272  0,005  Mucolytic
0,314  0,047  Antineoplastic (renal cancer)
0,284  0,020  Diabetic nephropathy treatment
0,270  0,009  Topoisomerase II alpha inhibitor
0,264  0,004  Estrogen receptor alpha agonist
0,264  0,005  Postmenopausal disorders treatment
0,307  0,049  Antineoplastic (liver cancer)
0,259  0,009  Androgen antagonist
0,253  0,004  Lipase inhibitor
0,254  0,005  Creatine kinase inhibitor
0,265  0,017  Glutathione S-transferase substrate
0,302  0,055  Transcription factor STAT inhibitor
0,268  0,022  Bone formation stimulant
0,253  0,008  Carbonic anhydrase XIII inhibitor
0,340  0,097  Antiprotozoal
0,266  0,026  Insulin sensitizer
0,249  0,010  UGT2B1 substrate
0,238  0,004  Ca(v)3.2 blocker
0,281  0,050  Antineoplastic (sarcoma)
0,254  0,024  Topoisomerase II inhibitor
0,296  0,069  Antineoplastic (multiple myeloma)
0,325  0,098  GST A substrate
0,232  0,007  NAD(P)H dehydrogenase (quinone) inhibitor
0,228  0,008  AMP-activated protein kinase stimulant
0,298  0,079  Antimycobacterial
0,291  0,073  5 Hydroxytryptamine release stimulant
0,248  0,033  Antiviral (Herpes)
0,271  0,057  Gastrin inhibitor
0,221  0,008  Gastritis treatment
0,289  0,079  Antineoplastic (osteosarcoma)
0,228  0,019  Antitussive
0,273  0,064  Tumour necrosis factor alpha release inhibitor
0,268  0,061  Antiglaucomic
0,223  0,020  Chelator
0,312  0,114  Atherosclerosis treatment
0,222  0,027  Antidiarrheal
0,243  0,050  Abortion inducer
0,211  0,019  Farnesoid X receptor antagonist
0,227  0,036  Antineoplastic (carcinoma)
0,280  0,091  CYP3A4 inhibitor
0,297  0,108  Stroke treatment
0,213  0,024  DNA polymerase I inhibitor
0,210  0,024  Arachidonic acid antagonist
0,262  0,078  Aldehyde oxidase inhibitor
0,218  0,036  Succinate dehydrogenase inhibitor
0,298  0,117  GABA C receptor rho-3 antagonist
0,183  0,005  Xanthine dehydrogenase inhibitor
0,194  0,017  Carbonic anhydrase III inhibitor
0,181  0,004  Neuraminidase inhibitor
0,197  0,022  Antineoplastic antibiotic
0,234  0,060  RNA-directed DNA polymerase inhibitor
0,221  0,048  Antipruritic, non-allergic
0,196  0,023  Antibacterial (Helicobacter pylori)
0,211  0,038  Cyclooxygenase inhibitor
0,192  0,023  Butyrylcholinesterase inhibitor
0,197  0,029  Neurotrophic factor
0,284  0,117  Ulceration
0,221  0,057  Non-steroidal antiinflammatory agent
0,185  0,022  SULT1A1 substrate
0,199  0,038  UGT2B10 substrate
0,180  0,024  Beta amyloid protein antagonist
0,211  0,055  Dual specificity phosphatase 3 inhibitor
0,174  0,018  Antineoplastic (uterine cancer)
0,205  0,050  LDLR expression enhancer
0,218  0,063  Antiviral (Influenza)
0,179  0,025  Microtubule formation inhibitor
0,195  0,043  Interferon gamma antagonist
0,157  0,006  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,170  0,020  HDL-cholesterol increasing
0,167  0,019  Multidrug resistance-associated protein 1 inhibitor
0,161  0,015  Opioid kappa receptor antagonist
0,208  0,062  CYP2B6 inhibitor
0,155  0,010  Leukotriene antagonist
0,148  0,005  Fatty acid synthase inhibitor
0,146  0,003  Retinoid X alpha receptor agonist
0,186  0,047  Death-associated protein kinase 2 inhibitor
0,164  0,026  Carbonic anhydrase XV inhibitor
0,143  0,007  SULT1A2 substrate
0,236  0,100  Antituberculosic
0,286  0,152  Antiparkinsonian
0,153  0,020  DOPA decarboxylase inhibitor
0,251  0,122  Angiogenesis inhibitor
0,175  0,047  Tubulin antagonist
0,200  0,072  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,253  0,125  Vasodilator, peripheral
0,211  0,085  Antineoplastic (lymphoma)
0,145  0,020  Phosphodiesterase 4D inhibitor
0,153  0,029  Photosensitizer
0,132  0,009  Neuraminidase (influenza) inhibitor
0,179  0,056  Interleukin 6 antagonist
0,138  0,016  Peroxisome proliferator-activated receptor gamma agonist
0,177  0,056  Antiviral (Influenza A)
0,141  0,023  Actinic keratosis treatment
0,253  0,136  Antiprotozoal (Plasmodium)
0,219  0,104  Tyrosine 3 hydroxylase inhibitor
0,160  0,047  Antifungal (Cryptococcus)
0,119  0,008  Carbonic anhydrase VII inhibitor
0,154  0,045  Cyclooxygenase 3 inhibitor
0,138  0,030  Urease inhibitor
0,116  0,009  Estradiol 17 beta-dehydrogenase inhibitor
0,148  0,041  Coagulant
0,129  0,022  Antiviral (Rhinovirus)
0,216  0,111  Immunostimulant
0,106  0,005  Transcription factor RelA inhibitor
0,105  0,004  Retinoid X receptor agonist
0,140  0,039  TRPA1 agonist
0,163  0,062  Antidote
0,152  0,052  Cyclooxygenase 2 inhibitor
0,127  0,029  UGT2B11 substrate
0,124  0,027  SULT1E1 substrate
0,213  0,118  Antineurogenic pain
0,146  0,052  Ca2+-transporting ATPase inhibitor
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,113  0,019  Antiviral (Hepatitis A)
0,139  0,046  Topoisomerase I inhibitor
0,103  0,010  Leukotriene B4 antagonist
0,152  0,060  Antiacne
0,163  0,071  Peroxidase inhibitor
0,097  0,007  Glucose-6-phosphate translocase inhibitor
0,125  0,034  Opioid antagonist
0,140  0,051  Skin irritative effect
0,168  0,078  Toxic, respiratory center
0,106  0,017  Aldose reductase inhibitor
0,160  0,071  Eye irritation, high
0,108  0,022  Leukotriene synthesis inhibitor
0,113  0,027  Bile acid receptor antagonist
0,277  0,192  5 Hydroxytryptamine release inhibitor
0,131  0,047  Antiviral (Influenza B)
0,092  0,008  Postcoital contraceptive
0,191  0,108  Platelet antagonist
0,121  0,042  Toll-Like receptor 4 antagonist
0,131  0,053  Contraceptive female
0,231  0,153  Vasodilator, coronary
0,088  0,011  Opioid kappa receptor agonist
0,158  0,082  Mcl-1 antagonist
0,117  0,042  Anabolic
0,142  0,068  Histone deacetylase SIRT1 inhibitor
0,099  0,026  HIV-1 integrase (3'-Processing) inhibitor
0,144  0,074  Adenylate cyclase stimulant
0,173  0,104  Cardiodepressant
0,111  0,043  Uric acid excretion stimulant
0,182  0,114  Antineoplastic (lymphocytic leukemia)
0,096  0,030  CDC25A inhibitor
0,134  0,067  Interleukin 4 antagonist
0,142  0,076  Antiprotozoal (Coccidial)
0,090  0,025  Antitreponemal
0,124  0,062  Proteasome inhibitor
0,129  0,067  Antiseptic
0,193  0,132  Huntington's disease treatment
0,213  0,154  Cholesterol antagonist
0,155  0,096  Amyloid beta precursor protein antagonist
0,063  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,147  0,090  Antihelmintic (Nematodes)
0,121  0,064  Alcohol dehydrogenase substrate
0,098  0,042  Dyspepsia treatment
0,077  0,021  Alpha tubulin antagonist
0,168  0,112  Angiogenesis stimulant
0,143  0,087  Movement disorders treatment
0,191  0,137  Antiviral (West Nile virus)
0,131  0,078  Psychosexual dysfunction treatment
0,220  0,166  FMO1 substrate
0,111  0,057  Mediator release inhibitor
0,130  0,077  Antifungal enhancer
0,107  0,056  Bronchodilator
0,087  0,037  Narcotic antagonist
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,144  0,094  Heat shock protein 90 alpha antagonist
0,179  0,130  Nitric-oxide synthase stimulant
0,106  0,058  Gastric antisecretory
0,074  0,026  Transcription factor AP-1 inhibitor
0,087  0,040  Keratolytic
0,226  0,180  Antiobesity
0,086  0,041  Antibiotic
0,144  0,099  Liver fibrosis treatment
0,081  0,036  Opioid delta receptor antagonist
0,066  0,022  Acetyl-CoA transferase 2 inhibitor
0,061  0,017  Cathepsin L2 inhibitor
0,106  0,063  Carcinogenic, group 2B
0,142  0,099  Prostate disorders treatment
0,116  0,074  Growth stimulant
0,265  0,223  Antineoplastic (solid tumors)
0,153  0,113  Antieczematic atopic
0,177  0,138  DNA damaging
0,212  0,172  Sodium/bile acid cotransporter inhibitor
0,074  0,035  Exportin-1 inhibitor
0,052  0,013  Retinoic acid alpha receptor agonist
0,135  0,097  MAP kinase kinase 4 inhibitor
0,082  0,045  Analgesic, opioid
0,062  0,025  Leukotriene C antagonist
0,138  0,102  Uterine stimulant
0,153  0,119  Antirickettsial
0,085  0,051  Carbonic anhydrase VI inhibitor
0,113  0,079  Aldehyde dehydrogenase inhibitor
0,103  0,069  Choleretic
0,100  0,069  Gout treatment
0,063  0,032  Protein kinase C eta inhibitor
0,110  0,080  Constipation treatment
0,067  0,037  HIV-1 integrase (Strand Transfer) inhibitor
0,041  0,011  Leukotriene B4 receptor 1 antagonist
0,092  0,064  Alpha 2d adrenoreceptor antagonist
0,059  0,031  Opioid agonist
0,051  0,023  Neuraminidase (Influenza A) inhibitor
0,044  0,016  Squalene synthetase inhibitor
0,072  0,045  Opioid mu receptor antagonist
0,040  0,013  Cholesterol ester transfer protein antagonist
0,069  0,042  Glucagon-like peptide 1 agonist
0,058  0,032  Dihydroorotate oxidase inhibitor
0,072  0,047  Peroxisome proliferator-activated receptor gamma antagonist
0,145  0,120  Psychostimulant
0,106  0,081  Alkylator
0,071  0,047  Secretase beta inhibitor
0,147  0,124  Antimitotic
0,052  0,030  Sodium/calcium exchanger inhibitor
0,068  0,047  Sirtuin 1 inhibitor
0,042  0,022  5-Alpha-reductase inhibitor
0,160  0,141  VEGF expression inhibitor
0,051  0,032  Squalene epoxidase inhibitor
0,037  0,019  Tubulin agonist
0,091  0,073  Phosphodiesterase 6D inhibitor
0,075  0,058  Macrophage migration inhibitory factor inhibitor
0,035  0,018  Estrogen-related receptor beta antagonist
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,047  0,032  Opioid mu receptor agonist
0,103  0,088  M18 aspartyl aminopeptidase inhibitor
0,039  0,025  Leukotriene C4 antagonist
0,067  0,053  HIV-1 integrase inhibitor
0,057  0,044  Sphingosine kinase inhibitor
0,024  0,012  Inosine monophosphate dehydrogenase 1 inhibitor
0,078  0,066  Inducible nitric-oxide synthase inhibitor
0,027  0,015  Sodium/glucose cotransporter inhibitor
0,078  0,067  Thioredoxin reductase inhibitor
0,023  0,014  Leukotriene B4 receptor 2 antagonist
0,025  0,016  Sodium/glucose cotransporter 1 inhibitor
0,054  0,048  Pregnane X receptor antagonist
0,020  0,016  Estrone sulfatase inhibitor
0,042  0,038  Microtubule stabilization
0,064  0,061  SULT2A1 substrate
0,057  0,055  CDC25B inhibitor
0,084  0,083  UDP-glucose 4-epimerase inhibitor
0,137  0,136  Phospholipase C inhibitor
0,133  0,133  Anesthetic general

